Forodesine hydrochloride (BCX-1777) (Synonyms: BCX-1777 hydrochloride; Immucillin-H hydrochloride) |
| Katalog-Nr.GC32708 |
Forodesin-Hydrochlorid (BCX-1777) (BCX-1777-Hydrochlorid) ist ein hochwirksamer und oral aktiver Purinnukleosid-Phosphorylase (PNP)-Inhibitor mit IC50-Werten im Bereich von 0,48 bis 1,57 nM fÜr PNP von Mensch, Maus, Ratte, Affe und Hund. Forodesinhydrochlorid (BCX-1777) ist ein potenter Inhibitor der menschlichen Lymphozytenproliferation. Forodesinhydrochlorid (BCX-1777) kÖnnte Apoptose in LeukÄmiezellen induzieren, indem es die dGTP-Spiegel erhÖht.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 284490-13-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Forodesine hydrochloride is a potent and oral purine nucleoside phosphorylase (PNP) inhibitor with IC50s ranging from 0.48 to 1.57 nM.
[1]. Homminga I, et al. In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia. Blood. 2011 Aug 25;118(8):2184-90. [2]. Ogura M, et al. Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies. Cancer Sci. 2012 Jul;103(7):1290-5. [3]. Bieghs L, et al. The effects of forodesine in murine and human multiple myeloma cells. Adv Hematol. 2010;2010:131895. [4]. Yamauchi T, et al. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine. Anticancer Res. 2014 Sep;34(9):4885-92.
Average Rating: 5 (Based on Reviews and 6 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *